aod9604 phase 2 trial weight loss results AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side effects. The clinical question AOD-9604 is the quiet powerhouse

Since this is a multi-dose vial with a preservative, it can be used for multiple doses in the same patient

If the person appears nervous or tense, advise them to put their weight on the leg or arm that you aren't injecting to help relax the muscles

Clinical studies show that while GLP-1 peptides like semaglutide and tirzepatide primarily reduce fat mass, some lean muscle is lost as well

Unlike with many of the other vitamins, B12 is not synthesized by the body

The peptide has been extensively studied in both preclinical models and human clinical trials, demonstrating consistent fat-reducing effects with a favorable safety profile

With the eight-zone rotation system described in this guide (four zones per thigh, alternating legs), each spot gets 7 weeks of rest between injections